These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24500903)

  • 1. Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer.
    Neslund-Dudas C; Levin AM; Rundle A; Beebe-Dimmer J; Bock CH; Nock NL; Jankowski M; Datta I; Krajenta R; Dou QP; Mitra B; Tang D; Rybicki BA
    Prostate; 2014 May; 74(6):637-46. PubMed ID: 24500903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead concentration in plasma as a biomarker of exposure and risk, and modification of toxicity by δ-aminolevulinic acid dehydratase gene polymorphism.
    Tian L; Zheng G; Sommar JN; Liang Y; Lundh T; Broberg K; Lei L; Guo W; Li Y; Tan M; Skerfving S; Jin T; Bergdahl IA
    Toxicol Lett; 2013 Aug; 221(2):102-9. PubMed ID: 23792432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.
    van Bemmel DM; Boffetta P; Liao LM; Berndt SI; Menashe I; Yeager M; Chanock S; Karami S; Zaridze D; Matteev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Slamova A; Rothman N; Han SS; Rosenberg PS; Brennan P; Chow WH; Moore LE
    PLoS One; 2011; 6(7):e20432. PubMed ID: 21799727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on relationships between biomarkers in workers with low-level occupational lead exposure].
    Yang H; Zhang H; Zhou Q; Gong W; Zhu B; Li W; Zhou Y
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Jun; 33(6):403-8. PubMed ID: 26653370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of delta-aminolevulinic acid dehydratase gene polymorphism on selected lead exposure biomarkers in a cohort of ex-smelter workers.
    Leroyer A; Leleu B; Dehon B; Frimat P; Broly F; Nisse C
    J Toxicol Environ Health A; 2013; 76(15):895-906. PubMed ID: 24156693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men.
    Neslund-Dudas C; Levin AM; Beebe-Dimmer JL; Bock CH; Nock NL; Rundle A; Jankowski M; Krajenta R; Dou QP; Mitra B; Tang D; Rebbeck TR; Rybicki BA
    Cancer Causes Control; 2014 Jul; 25(7):869-79. PubMed ID: 24801046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility of δ-ALAD associated with lead (Pb) intoxication: sources of exposure, preventive measures, and treatment interventions.
    Qader A; Rehman K; Akash MSH
    Environ Sci Pollut Res Int; 2021 Sep; 28(33):44818-44832. PubMed ID: 34244947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Generalized Additive Model to Detect the Threshold of δ-Aminolevulinic Acid Dehydratase Activity Reduced by Lead Exposure.
    Huang CC; Yang CC; Liu TY; Dai CY; Wang CL; Chuang HY
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Lead Exposure and Genetic Polymorphisms on ALAD and GPx Activities in Brazilian Battery Workers.
    da Cunha Martins A; Mazzaron Barcelos GR; Jacob Ferreira AL; de Souza MF; de Syllos Cólus IM; Antunes LM; Paoliello MMB; Adeyemi JA; Barbosa F
    J Toxicol Environ Health A; 2015; 78(16):1073-81. PubMed ID: 26275098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying effects of δ-Aminolevulinate dehydratase polymorphism on blood lead levels and ALAD activity.
    Mani MS; Kunnathully V; Rao C; Kabekkodu SP; Joshi MB; D'Souza HS
    Toxicol Lett; 2018 Oct; 295():351-356. PubMed ID: 30025905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility to low-level lead exposure in men: Insights from ALAD polymorphisms.
    Stajnko A; Palir N; Snoj Tratnik J; Mazej D; Sešek Briški A; Runkel AA; Horvat M; Falnoga I
    Int J Hyg Environ Health; 2024 Mar; 256():114315. PubMed ID: 38168581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging Study.
    Weuve J; Kelsey KT; Schwartz J; Bellinger D; Wright RO; Rajan P; Spiro A; Sparrow D; Aro A; Hu H
    Occup Environ Med; 2006 Nov; 63(11):746-53. PubMed ID: 16757504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association of delta-aminolevulinic acid dehydratase genotype with cytogenetic damage in lead workers.
    Wu FY; Chang PW; Wu CC; Lai JS; Kuo HW
    Int Arch Occup Environ Health; 2004 Aug; 77(6):395-400. PubMed ID: 15258767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate kinase activity and δ-aminolevulinic acid dehydratase activity as biomarkers of toxicity in workers exposed to lead.
    Feksa LR; Oliveira E; Trombini T; Luchese M; Bisi S; Linden R; Berlese DB; Rojas DB; Andrade RB; Schuck PF; Lacerda LM; Wajner M; Wannmacher CM; Emanuelli T
    Arch Environ Contam Toxicol; 2012 Oct; 63(3):453-60. PubMed ID: 22864587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio.
    Montenegro MF; Barbosa F; Sandrim VC; Gerlach RF; Tanus-Santos JE
    Arch Toxicol; 2006 Jul; 80(7):394-8. PubMed ID: 16341691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.
    Smith CM; Wang X; Hu H; Kelsey KT
    Environ Health Perspect; 1995 Mar; 103(3):248-53. PubMed ID: 7768225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ALAD polymorphism and indicators of dose and effects of occupational exposure to inorganic lead].
    De Palma G; Scotti E; Mozzoni P; Alinovi R; Apostoli P; Neri G; Soleo L; Cassano F; Carta P; Murgia N; Muzi G; Muttil A
    G Ital Med Lav Ergon; 2005; 27 Suppl 1():39-42. PubMed ID: 15915653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study.
    Wu MT; Kelsey K; Schwartz J; Sparrow D; Weiss S; Hu H
    Environ Health Perspect; 2003 Mar; 111(3):335-41. PubMed ID: 12611663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study.
    Hu H; Wu MT; Cheng Y; Sparrow D; Weiss S; Kelsey K
    Environ Health Perspect; 2001 Aug; 109(8):827-32. PubMed ID: 11564619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes.
    Schwartz BS; Lee BK; Lee GS; Stewart WF; Simon D; Kelsey K; Todd AC
    Environ Health Perspect; 2000 Oct; 108(10):949-54. PubMed ID: 11049814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.